gadomer 17

Known as: gadomer-17 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2006
024619982006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Sentinel node imaging is commonly performed prior to surgery for breast cancer and melanoma. While current methods are based on… (More)
Is this relevant?
2004
2004
PURPOSE To test magnetic resonance (MR) contrast media of different molecular weights (MWs) for their potential to characterize… (More)
Is this relevant?
2002
2002
PURPOSE To evaluate the enhancement of regional lymph nodes and lymphatic vessels after intramammary injection of Gadomer-17… (More)
Is this relevant?
2002
2002
OBJECTIVE The goals of our study were to determine the technical feasibility of dynamic MR lymphangiography for detecting… (More)
Is this relevant?
2002
2002
RATIONALE AND OBJECTIVES The detection of lymph node metastases is an important step in tumor staging and is significant for… (More)
Is this relevant?
2001
2001
Rationale and objectives: Gadomer-17 is a new magnetic resonance (MR) contrast medium presently in clinical development. It is a… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2001
2001
The goal of this study was visualisation and quality assessment of the pulmonary arteries in pigs with modified navigator-echo… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 4
Is this relevant?
2000
2000
A technique for the simultaneous measurement of three vascular parameters: blood flow (Frho), blood volume (v(b)), and the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2000
2000
RATIONALE AND OBJECTIVES This study compared gadopentetate dimeglumine (molecular weight, 0.5 kD), a standard contrast medium… (More)
Is this relevant?
1998
1998
RATIONALE AND OBJECTIVES Our purpose was to investigate a "blood pool" contrast agent for abdominal and thoracic MR angiography… (More)
Is this relevant?